Personalized neoantigen vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Personalized neoantigen vaccine, covering 2025-07-16 to 2025-10-22. Get the full timeline:
Most recent: Clinical Trial Update: Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer [Phase 2]